Home
Conditions
Localized Unresectable Adult Primary Liver Cancer

Clinical trial condition

Localized Unresectable Adult Primary Liver Cancer

Explore clinical trials studying Localized Unresectable Adult Primary Liver Cancer. Study availability and eligibility vary by location and protocol.

23 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Localized Unresectable Adult Primary Liver Cancer trial results

Completed

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

NCT01624285

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Carcinoma, +12 more
Locations: University of Alabama Birmingham, Alabama, United States

Jonsson Comprehensive Cancer Center Los Angeles, California, United States

University of Colorado Denver, Colorado, United States

Mount Sinai Hospital Hartford, Connecticut, United States

View all 21 locations

View Trial Details

Completed

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

NCT02072356

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +12 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

NCT01643499

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of Unknown Primary, Adenocarcinoma of the Gallbladder, +67 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Evanston CCOP-NorthShore University HealthSystem Evanston, Illinois, United States

View Trial Details

Completed

CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery

NCT01766219

Conditions: Adenocarcinoma, Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, +21 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery

NCT00101036

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +22 more
Locations: UC Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Completed

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

NCT00321594

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +12 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

Cancer Therapeutics Research Group Singapore

View Trial Details

Completed

Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer

NCT00055692

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Carcinoma, +11 more
Locations: Montefiore Medical Center - Moses Campus The Bronx, New York, United States

View Trial Details

Completed

Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer

NCT00365391

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +12 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

NCT00107536

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +22 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

NCT00006016

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +11 more
Locations: New York University Langone Medical Center New York, United States

View Trial Details

Localized Unresectable Adult Primary Liver Cancer

Localized Unresectable Adult Primary Liver Cancer trial results

Related conditions